
If you’re undergoing radiotherapy for head and neck cancer, you may have heard about oral mucositis—a painful side effect that can make eating, drinking, and speaking difficult. Recent research suggests that Limosilactobacillus reuteri, a beneficial probiotic strain, could help reduce its severity. At Melbourne Oral Medicine, we stay updated with the latest evidence-based treatments to support your oral health during cancer care. Here’s what you need to know about this emerging option.
Oral mucositis is inflammation and ulceration of the mouth’s lining, often caused by high-dose radiotherapy or chemotherapy. It typically appears within 1–2 weeks of treatment and can last for several weeks, leading to symptoms like:
While oral mucositis is common in cancer patients, its severity can vary. If symptoms become severe—such as persistent bleeding, fever, or difficulty breathing—seek medical attention immediately.
A 2024 study published in Nature Communications explored the use of Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) as a preventive measure for radiation-induced oral mucositis. The research found that this probiotic strain may help reduce inflammation and promote healing by modulating the gut-mouth axis and supporting immune balance. While more clinical trials are needed, early results are promising for patients undergoing radiotherapy.

If you’re experiencing persistent mouth sores or discomfort during or after radiotherapy, it’s crucial to rule out complications like infections or late-stage damage. A remote consultation with our Oral Medicine Specialist, Dr Suhaib Alqudah, can help assess your symptoms without the need for travel. During your telehealth appointment, we may:
This approach ensures you receive personalised care while minimising unnecessary clinic visits.
While mild oral mucositis may resolve on its own with supportive care, seek professional advice if you experience:
Our Australia-wide telehealth consultations allow you to discuss these concerns with Dr Alqudah from the comfort of home, ensuring timely intervention.

At our clinic, we specialise in managing complex oral conditions, including those related to cancer treatment. Whether you’re exploring L. reuteri as a preventive measure or need guidance on managing existing symptoms, our team provides evidence-based advice tailored to your needs. We also collaborate closely with oncologists, GPs, and dentists to ensure coordinated care.
If you’re worried about oral mucositis or want to discuss emerging treatments like L. reuteri, book a secure video consultation today. Your oral health matters, and we’re here to help.
No, L. reuteri is not a standalone cure but may be used as a supportive measure alongside standard care, such as mouth rinses and pain management. Always follow your oncologist’s recommendations and consult our team for personalised advice.
While generally considered safe, L. reuteri may interact with certain medications or immune-suppressing treatments. Dr Alqudah will assess whether it’s suitable for your specific case during your consultation.
Effects vary by individual, but some patients report reduced inflammation within weeks of starting L. reuteri. Consistency and proper oral hygiene are key to seeing benefits.
#Radiationinducedoralmucositis #Limosilactobacillusreuteri #Cancerpatientoralcare #Telehealthoralmedicine #Supportivecancertreatment
Have a question? Our team can help — book a consultation or explore our services. Book a consultation or explore our services.
Add Comment